Navigation Links
Omnicare Clinical Research Licenses LiquentConnect to Create Added Value for Clients
Date:1/26/2010

PHILADELPHIA, Jan. 26 /PRNewswire/ -- Liquent, Inc. today announced Omnicare Clinical Research has licensed LiquentConnect® - a hosted software as a service (SaaS) solution used to quickly and easily create, review, amend and submit regulatory dossiers.  Omnicare Clinical Research is a leading Phase I to IV global contract research organization serving the biopharmaceutical and medical device industries.

LiquentConnect enables organizations to produce their own eCTD and non electronic submissions without investing in IT infrastructure.  All software and hardware upgrades are managed and executed by Liquent.  LiquentConnect is fully executable for eCTD, NeeS and CTD publishing.  

"As portions of the industry shift toward SaaS, we are pleased to offer LiquentConnect, a SaaS solution publishing tool," said Rick Riegel, Liquent's Chief Executive Officer. "Liquent is committed to providing value-add solutions to our customers.  LiquentConnect provides reliable, secure access to your dossiers from anywhere with an internet connection."

Omnicare Clinical Research selected Liquent and will be utilizing LiquentConnect as its hosted solution provider due to Liquent's depth of expertise within the regulatory and life-sciences industry.  The benefits of implementing a fully-managed SaaS solution outweighed the time and resource investment required for other solutions.  

"LiquentConnect provides our organization and our customers with project submission data that is safe and secure.  Liquent provided us with a solution that is not only flexible, but one that we believe can expand to meet our needs and offer an efficient and cost-effective tool to address a variety of situations, from eCTD to NeeS to paper," said Dr. Martine Dehlinger-Kremer, Vice President of Global Regulatory Affairs for Omnicare Clinical Research.  

About Omnicare Clinical Research

Established in 1985, Omnicare Clinical Research is a full-service CRO, with diverse therapeutic expertise and comprehensive clinical service offerings, supporting the pharmaceutical industry throughout every aspect of a clinical project. Furthermore, the Company features specialized expertise in phase I-III clinical services, clinical supplies packaging, labeling, storage and distribution services, and functional service provider relationships from its office locations in over 30 countries worldwide. Omnicare Clinical Research is a subsidiary of Omnicare, Inc. (NYSE: OCR), a leading provider of pharmacy services to long-term care facilities and other chronic care settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada. www.omnicareCR.com.

About Liquent, Inc.

Liquent regulatory solutions provide software and related regulatory and clinical services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time.  For more information please visit, www.liquent.com.

SOURCE Liquent, Inc.

RELATED LINKS
http://www.liquent.com

'/>"/>

SOURCE Liquent, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Telik Announces Initiation of Phase 1 Clinical Study of Ezatiostat Hydrochloride (TELINTRA(R), TLK199) Tablets in Combination With Lenalidomide (Revlimid(R)) in Patients With Myelodysplastic Syndrome (MDS)
2. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
3. Clinical Data Presented at Asia PCR/Sing LIVE Demonstrate Benefits of OrbusNeichs Genous(TM) Bio-engineered R stent(TM) in Challenging Patient Subsets
4. Michael J. Fox Foundation Awards $2.1 Million to Drive Six Industry Teams Pre-Clinical Development of Neuroprotective Parkinsons Therapies
5. Circassia Extends its Clinical-Stage Portfolio With Phase II Trials of T-Cell Vaccines Against House Dust Mite and Cat Allergies
6. ERT Demonstrates Patient Safety Expertise in Clinical Trials with New Knowledge Series of Papers
7. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
8. Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes
9. Enbrel Will Remain Decision Resources Clinical Gold Standard Through 2018 for the Treatment of Rheumatoid Arthritis
10. PharmaNet Development Group Symposia Crossing the Bridge from Preclinical to Clinical Studies to be Held February 2010 in Basel, Dusseldorf and Vienna
11. Soligenix Announces Publication of Positive Pre-Clinical Results with RiVax(TM), Its Vaccine Against Ricin Toxin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG Innotek ... Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls ... Strahlung im Bereich zwischen 200 und 280 nm und eignet ... Bakterien, indem es ihre DNA zerstört. Das Produkt von ... ...
(Date:2/23/2017)... Im Rahmen seiner Schlüsselwachstumsstrategie arbeitet die ... südwestlichen chinesischen Provinz Guizhou, 2017 mit dem Angebot von Anreize ... der Entwicklung einer eingebetteten Hightech-Schlüsselindustrie. Foto - ... ... ...
(Date:2/23/2017)... , February 23, 2017 ... from increasing caseload for varicose veins in their body. ... globe are prompting the adoption of endovenous laser therapy ... global endovenous laser therapy market, published by ... of lifestyle choices and consequences of obesity have collectively ...
Breaking Medicine Technology:
(Date:2/23/2017)... ... 2017 , ... Hamlin Dental Group and Dr. Hamid Reza, dentist in ... the month of February, patients who visit Hamlin Dental Group will receive a ticket ... two at the Cheesecake Factory. , Tickets are available for routine dental visits ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... in clinical trials, today announced that Premier Research, a leading clinical development service ... Clinical trials are becoming increasingly complex, due in part to an array of ...
(Date:2/23/2017)... ... 2017 , ... The Center for Autism and Related Disorders ... Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The events ... films in an environment that accommodates their unique needs. , Launched in January, ...
(Date:2/23/2017)... ... February 23, 2017 , ... Top cosmetic and periodontal dentist ... program today with a new Indiegogo campaign . Individuals are now able to ... the Los Angeles area, either as a participating patient or through an Indiegogo donation. ...
Breaking Medicine News(10 mins):